Effects of cessation of a policy of neonatal fluconazole prophylaxis on fungal resurgence.
dc.contributor.author | Dutta, Sourabh | en_US |
dc.contributor.author | Murki, Srinivas | en_US |
dc.contributor.author | Varma, Sanjeev | en_US |
dc.contributor.author | Narang, Anil | en_US |
dc.contributor.author | Chakrabarti, Arunaloke | en_US |
dc.date.accessioned | 2005-12-21 | en_US |
dc.date.accessioned | 2009-05-27T05:04:21Z | |
dc.date.available | 2005-12-21 | en_US |
dc.date.available | 2009-05-27T05:04:21Z | |
dc.date.issued | 2005-12-21 | en_US |
dc.description.abstract | Fluconazole has been used as prophylaxis against systemic fungal infections in preterm neonates. We conducted a study to determine whether cessation of a policy of prophylactic fluconazole results in a resurgence of fungal infections in a unit. Neonates born in the 3 epoches: A 36-month pre-Fluconazole prophylaxis epoch (Group 1), a 21-month Fluconazole prophylaxis epoch (Group 2) and a 39-month post Fluconazole prophylaxis epoch (Group 3) were compared for incidence and onset of fungal sepsis and resistance patterns. There was a decline in the incidence of fungal sepsis from Group 1 to Group 2, and it remained stable from Group 2 to Group 3. There was no significant difference in resistance to Fluconazole and to any of the azoles in Groups 1, 2 and 3 respectively. | en_US |
dc.description.affiliation | Division of Neonatology, Department of Pediatrics, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160 012, India. sourabhdutta@yahoo.co.in | en_US |
dc.identifier.citation | Dutta S, Murki S, Varma S, Narang A, Chakrabarti A. Effects of cessation of a policy of neonatal fluconazole prophylaxis on fungal resurgence. Indian Pediatrics. 2005 Dec; 42(12): 1226-30 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/7921 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://indianpediatrics.net | en_US |
dc.subject.mesh | Antifungal Agents --therapeutic use | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Fluconazole --therapeutic use | en_US |
dc.subject.mesh | Fungemia --epidemiology | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Incidence | en_US |
dc.subject.mesh | India --epidemiology | en_US |
dc.subject.mesh | Infant, Newborn | en_US |
dc.subject.mesh | Intensive Care Units, Neonatal --organization & administration | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Organizational Policy | en_US |
dc.subject.mesh | Retrospective Studies | en_US |
dc.title | Effects of cessation of a policy of neonatal fluconazole prophylaxis on fungal resurgence. | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1